Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
174.94
-0.90 (-0.51%)
Dec 10, 2025, 12:05 PM EST - Market open
Biogen Analyst Ratings
Total Analysts
22
Consensus Rating
Buy
Price Target
$174.55
Upside
-0.22%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HSBC | HSBC | Hold → Sell Downgrades $144 → $143 | Hold → Sell | Downgrades | $144 → $143 | -18.26% | Dec 10, 2025 |
| Piper Sandler | Piper Sandler | Hold Reiterates $118 → $157 | Hold | Reiterates | $118 → $157 | -10.25% | Nov 21, 2025 |
| Stifel | Stifel | Hold → Strong Buy Upgrades $144 → $202 | Hold → Strong Buy | Upgrades | $144 → $202 | +15.47% | Nov 6, 2025 |
| Bernstein | Bernstein | Hold Maintains $155 → $157 | Hold | Maintains | $155 → $157 | -10.25% | Nov 3, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $217 → $210 | Buy | Maintains | $217 → $210 | +20.04% | Oct 31, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $144 → $149 | Hold | Maintains | $144 → $149 | -14.83% | Oct 10, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $190 | Strong Buy | Initiates | $190 | +8.61% | Sep 25, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 24, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 4, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $115 → $118 | Hold | Maintains | $115 → $118 | -32.55% | Aug 14, 2025 |
| Citigroup | Citigroup | Hold Maintains $125 → $135 | Hold | Maintains | $125 → $135 | -22.83% | Aug 1, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $208 → $219 | Buy | Maintains | $208 → $219 | +25.19% | Aug 1, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $146 → $144 | Hold | Maintains | $146 → $144 | -17.69% | Aug 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $187 → $194 | Strong Buy | Maintains | $187 → $194 | +10.90% | Aug 1, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $213 → $208 | Buy | Maintains | $213 → $208 | +18.90% | Jul 7, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $213 | Buy | Reiterates | $213 | +21.76% | Jun 27, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.